NCT01770613View on ClinicalTrials.gov

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2017

Conditions
ST Segment Elevation Myocardial Infarction (STEMI)Allogeneic Mesenchymal Bone Marrow Cells
Interventions
BIOLOGICAL

Stem cells

Allogeneic mesenchymal stem cells

Trial Locations (2)

30033

Emory University Hospital, Atlanta

85224

Mercy Gilbert and Chandler Medical Center, Gilbert

Sponsors

Collaborators (1)

CardioCell LLC
All Listed Sponsors
collaborator

CardioCell LLC

INDUSTRY

lead

Stemedica Cell Technologies, Inc.

INDUSTRY

NCT01770613 - A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI) | Biotech Hunter | Biotech Hunter